Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 25 8 2020
medline: 22 12 2020
entrez: 25 8 2020
Statut: ppublish

Résumé

Infection by severe acute respiratory syndrome coronavirus-2 can induce uncontrolled systemic inflammation and multiple organ failure. The aim of this study was to evaluate if plasma exchange, through the removal of circulating mediators, can be used as rescue therapy in these patients. Single center case series. Local study. Four critically ill adults with coronavirus disease 19 pneumonia that failed conventional interventions. Plasma exchange. Two to six sessions (1.2 plasma volumes). Human albumin (5%) was used as the main replacement fluid. Fresh frozen plasma and immunoglobulins were administered after each session to avoid coagulopathy and hypogammaglobulinemia. Serum markers of inflammation and macrophage activation. All patients showed a dramatic reduction in inflammatory markers, including the main cytokines, and improved severity scores after plasma exchange. All survived to ICU admission. Plasma exchange mitigates cytokine storm, reverses organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 infection.

Identifiants

pubmed: 32833695
doi: 10.1097/CCM.0000000000004613
pmc: PMC7493773
pii: 00003246-202012000-00070
doi:

Substances chimiques

Cytokines 0
Inflammation Mediators 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1350-e1355

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

J Hepatol. 2014 Aug;61(2):396-407
pubmed: 24751830
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Br J Haematol. 2014 Feb;164(3):342-51
pubmed: 24172059
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Clin Exp Immunol. 2004 Apr;136(1):95-103
pubmed: 15030519
Pediatr Crit Care Med. 2011 Mar;12(2):e87-9
pubmed: 20453703
Sci Rep. 2016 May 05;6:25359
pubmed: 27146253
J Clin Apher. 2018 Feb;33(1):117-120
pubmed: 28730667
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Crit Care Med. 2016 Feb;44(2):275-81
pubmed: 26584195
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717

Auteurs

Javier Fernandez (J)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.
EF Clif, EASL-CLIF Consortium, Barcelona, Spain.

Jordi Gratacos-Ginès (J)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Pol Olivas (P)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Montserrat Costa (M)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Susana Nieto (S)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Dolors Mateo (D)

Apheresis Unit, Hemotherapy and Hemostasis Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

María Belén Sánchez (MB)

CDB, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Ferran Aguilar (F)

EF Clif, EASL-CLIF Consortium, Barcelona, Spain.

Octavi Bassegoda (O)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Pablo Ruiz (P)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Berta Caballol (B)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Anna Pocurull (A)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Joan Llach (J)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

María Jesús Mustieles (MJ)

Apheresis Unit, Hemotherapy and Hemostasis Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

Joan Cid (J)

Apheresis Unit, Hemotherapy and Hemostasis Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

Enric Reverter (E)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Nestor David Toapanta (ND)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

María Hernández-Tejero (M)

Liver ICU, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

José Antonio Martínez (JA)

Infectious Disease Department, Hospital Clinic, Barcelona, Spain.

Joan Claria (J)

EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
CDB, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.

Carlos Fernández (C)

Medical Emergency Service, Berga, Catalonia, Spain.

José Mensa (J)

Infectious Disease Department, Hospital Clinic, Barcelona, Spain.

Vicente Arroyo (V)

EF Clif, EASL-CLIF Consortium, Barcelona, Spain.

Pedro Castro (P)

Medical intensive Care Unit, Internal Medicine Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

Miquel Lozano (M)

Apheresis Unit, Hemotherapy and Hemostasis Department, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH